类衍生物在试验中通过激活PPARγ减轻动物的关节炎
Lijun Yu1,2, Tingting Luo2,3, Dandan Wang2,3
1School of Pharmacy, Anhui College of Traditional Chinese Medicine, Wuhu, China.
Natural product research
|August 31, 2025
概括
这种草药配方Qing-Luo-Yin (QLY) 激活PPARγ,减少关节炎和炎症. 这种激活通过调节炎症反应和脂肪利用来改善免疫和代谢健康.
科学领域:
- 药理学
- 免疫学
- 代谢疾病
背景情况:
- 青露 (QLY) 的草药配方因其潜在的治疗效果而闻名.
- 过氧体增殖器激活受体玛 (PPARγ) 是代谢和炎症的关键调节剂.
- 了解QLY的分子机制对于其在治疗关节炎等炎症性疾病中的应用至关重要.
研究的目的:
- 研究PPARγ激活在QLY抗风湿作用中的作用.
- 确定与PPARγ相互作用的QLY中的特定化合物.
- 阐明QLY介导的PPARγ激活对免疫和代谢途径的下游影响.
主要方法:
- 用于选和验证PPARγ激动剂的分子对接和体外实验.
- 针对抗原诱导性关节炎 (AA) 和辅助剂诱导性关节炎 (AIA) 的小鼠模型,使用了QLY,PPARγ抗剂 (T0070907) 和激动剂 (罗西格利塔).
- 血清化合物的分析,肝细胞脂肪利用和单细胞炎症细胞因子分泌.
主要成果:
- 在AA小鼠中,QLY和罗西格利塔改善了关节炎,炎症和脂质消耗,而T0070907减弱了QLY的作用.
- 在QLY中丰富的matrine,sophocarpine和sinomenine对PPARγ具有很高的亲和力,增强了它的活性.
- 通过QLY诱导的PPARγ激活抑制了脂肪利用,从而通过p65酸化抑制减少了促炎细胞因子的分泌 (TNF-ɑ,IL-6,IL-1β).
结论:
- 在QLY中的某些化物激活PPARγ信号,有助于其抗风湿性质.
- QLY改善了免疫和代谢环境,为炎症和代谢疾病提供了潜在的治疗策略.
- 这些发现突显了在关节炎治疗中代谢调节和免疫反应之间的复杂联系.
更多相关视频
06:14Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective
Published on: January 12, 2024
2.0K
07:20Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
Published on: August 23, 2024
643
相关概念视频
NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
GPCRs Regulate Adenylyl Cylase Activity
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Two...
Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
